cdn mobile

Archbishop Palma receives first dose of vaccine

By: Futch Anthony Inso - CDN Digital | April 13,2021 - 04:03 PM

Archbishop

Cebu Archbishop Jose Palma | CDN Digital File Photo 2021

LAPU-LAPU CITY, Cebu—Cebu Archbishop Jose Palma said he already received the first dose of the Coronavirus Disease 2019 (COVID-19) vaccine last week.

This was confirmed by Palma in a press briefing with the members of the media on Tuesday, April 13, 2021.

Aside from him, Palma said that there were also a few members of the Catholic Church who received the vaccine such as Auxiliary Bishop Midyphil Billones.

According to Palma that they were inoculated with the SinoVac vaccine  in coordination with the Project Balik Buhay.

As of the moment, Palma said that they are preparing the masterlist for other priests who will be given priority in the vaccination drive, especially those who are senior citizens and with comorbidities.

“Now, we are going to listing and prioritizing. We believe there are others who should be ahead of us and I know of doctors and those medical practitioners who were given ahead of us. So we just rely on the Project Balik Buhay,” he said.

Palma said he is also scheduled to receive the second dose of the vaccine on May 6, 2021.

It can be recalled that last February, Palma tested positive for COVID-19 but has since recovered.

Read: Archbishop Palma is COVID-19 positive

/bmjo

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: Cebu Archbishop Jose Palma, Project Balik Buhay, Sinovac
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.